{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T14:10:25Z","timestamp":1784383825749,"version":"3.55.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2003,5,25]],"date-time":"2003-05-25T00:00:00Z","timestamp":1053820800000},"content-version":"vor","delay-in-days":1027,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1053\/bega.2000.0109","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T09:54:50Z","timestamp":1032429290000},"page":"643-655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Pruritus and fatigue in primary biliary cirrhosis"],"prefix":"10.1053","volume":"14","author":[{"given":"Nora V","family":"Bergasa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay K","family":"Mehlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.Anthony","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/bega.2000.0109_RF1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJM197309272891306","article-title":"The presentation and diagnosis of 100 patients with primary biliary cirrhosis","volume":"289","author":"Sherlock","year":"1973","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0109_RF2","first-page":"587","article-title":"Asymptomatic primary biliary cirrhosis. Presentation, histology, and results with D-penicillamine","volume":"53","author":"Fleming","year":"1978","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1053\/bega.2000.0109_RF3","first-page":"1278","article-title":"Primary biliary cirrhosis\u2014a revised clinical spectrum","volume":"i","author":"James","year":"1981","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0109_RF4","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1440-1746.1990.tb01118.x","article-title":"Primary biliary cirrhosis: clinicopathological characteristics and outcome","volume":"5","author":"Jeffrey","year":"1990","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2000.0109_RF5","first-page":"307","article-title":"Primary biliary cirrhosis: current modes of presentation. Clinical, biochemical, immunologic and histologic study of 206 patients seen from 1978 to 1988","volume":"14","author":"Brenard","year":"1990","journal-title":"Gastroenterologie Clinique et Biologie"},{"key":"10.1053\/bega.2000.0109_RF6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-2007-1007360","article-title":"The pruritus of cholestasis","volume":"13","author":"Bergasa","year":"1993","journal-title":"Seminars in Liver Disease"},{"key":"10.1053\/bega.2000.0109_RF7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1572-0241.2000.01774.x","article-title":"Cholestatic liver diseases and health-related quality of life","volume":"95","author":"Younossi","year":"2000","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2000.0109_RF8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0035-8819(25)00956-0","article-title":"Liver transplantation","volume":"27","author":"Elias","year":"1993","journal-title":"Journal of the Royal College of Physicians (London)"},{"key":"10.1053\/bega.2000.0109_RF9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0168-8278(99)80098-1","article-title":"Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC Group","volume":"30","author":"Poupon","year":"1999","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0109_RF10","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1136\/bmj.2.4797.1289","article-title":"Testosterone therapy for the pruritus of obstructive jaundice","volume":"2","author":"Lloyd-Thomas","year":"1952","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.2000.0109_RF11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/bmj.4.5946.693","article-title":"Pruritic effect of bile salts","volume":"4","author":"Kirby","year":"1974","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.2000.0109_RF12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/gut.13.3.201","article-title":"Serum bile acids in primary biliary cirrhosis","volume":"13","author":"Murphy","year":"1972","journal-title":"Gut"},{"key":"10.1053\/bega.2000.0109_RF13","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/0002-9343(81)90857-3","article-title":"Pruritus in cholestasis: no direct causative role for bile acid retention","volume":"70","author":"Freedman","year":"1981","journal-title":"American Journal of Medicine"},{"key":"10.1053\/bega.2000.0109_RF14","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(59)91527-2","article-title":"Serum-bile acids levels in liver disease","volume":"ii","author":"Osborn","year":"1959","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0109_RF15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00005792-195012000-00002","article-title":"Primary biliary cirrhosis","volume":"29","author":"Ahrens","year":"1950","journal-title":"Medicine"},{"key":"10.1053\/bega.2000.0109_RF16","first-page":"603","article-title":"Pruritus of chronic cholestasis","volume":"88","author":"Raiford","year":"1995","journal-title":"Quarterly Journal of Medicine"},{"key":"10.1053\/bega.2000.0109_RF17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0016-5085(66)80071-9","article-title":"Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis","volume":"50","author":"Datta","year":"1966","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0109_RF18","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0016-5085(88)90442-8","article-title":"Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial","volume":"94","author":"Ghent","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0109_RF19","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0140-6736(89)91608-5","article-title":"Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis","volume":"i","author":"Bachs","year":"1989","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0109_RF20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/BF01308307","article-title":"Rifampicin-induced elevation of serum bile acids in man","volume":"25","author":"Galeazzi","year":"1980","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1053\/bega.2000.0109_RF21","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/0016-5085(92)90335-V","article-title":"Effects of long-term rifampicin administration in primary biliary cirrhosis","volume":"102","author":"Bachs","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0109_RF22","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJM197605132942008","article-title":"Rifampicin-induced methadone withdrawal","volume":"294","author":"Kreek","year":"1979","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0109_RF23","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0016-5085(93)90858-A","article-title":"Subhypnotic doses of propofol relieve pruritus associated with liver disease","volume":"104","author":"Borgeat","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0109_RF24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/00000542-199204000-00004","article-title":"Subhypnotic doses of propofol relieve pruritus induced by epidural and intrathecal morphine","volume":"76","author":"Borgeat","year":"1992","journal-title":"Anesthesiology"},{"key":"10.1053\/bega.2000.0109_RF25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0016-5085(90)91250-A","article-title":"Oral S -adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study","volume":"99","author":"Frezza","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0109_RF26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0168-8278(05)80122-9","article-title":"Epomediol ameliorates pruritus in patients with intrahepatic cholestasis of pregnancy","volume":"16","author":"Gonzalez","year":"1992","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0109_RF27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0002-9343(87)90861-8","article-title":"S -adenosylmethionine and affective disorder","volume":"83","author":"Carney","year":"1987","journal-title":"American Journal of Medicine"},{"key":"10.1053\/bega.2000.0109_RF28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.7326\/0003-4819-82-3-310","article-title":"Phenobarbital effects in cholestatic liver diseases","volume":"82","author":"Bloomer","year":"1975","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.2000.0109_RF29","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0140-6736(80)91849-8","article-title":"Phototherapy for pruritus in primary biliary cirrhosis","volume":"ii","author":"Hanid","year":"1980","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0109_RF30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(73)90055-X","article-title":"Intravenous lignocaine for relief of intractable itch","volume":"i","author":"Watson","year":"1973","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0109_RF31","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1440-1746.1999.01968.x","article-title":"Case report: oral antioxidant therapy for the treatment of primary biliary cirrhosis: a pilot study","volume":"14","author":"Watson","year":"1999","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2000.0109_RF32","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/bmj.296.6622.607","article-title":"Effect of stanozolol on itching in primary biliary cirrhosis","volume":"296","author":"Walt","year":"1988","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.2000.0109_RF33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2036.1994.tb00297.x","article-title":"Flumecimol for the treatment of pruritus associated with primary biliary cirrhosis","volume":"8","author":"Turner","year":"1994","journal-title":"Alimentary and Pharmacological Therapeutics"},{"key":"10.1053\/bega.2000.0109_RF34","first-page":"403","article-title":"Plasmaperfusion for the treatment of intractable pruritus of cholestasis","volume":"53","author":"Lauterburg","year":"1978","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1053\/bega.2000.0109_RF35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/gut.26.3.291","article-title":"Role of plasmapheresis in primary biliary cirrhosis","volume":"26","author":"Cohen","year":"1985","journal-title":"Gut"},{"key":"10.1053\/bega.2000.0109_RF36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0016-5085(88)90301-0","article-title":"Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis","volume":"95","author":"Whitington","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0109_RF37","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0022-3468(98)90435-3","article-title":"Ileal exclusion for Byler's disease: an alternative surgical approach with promising early results for pruritus","volume":"33","author":"Hollands","year":"1998","journal-title":"Journal of Paediatric Surgery"},{"key":"10.1053\/bega.2000.0109_RF38","first-page":"295","article-title":"Pilot study of low-dose oral methotrexate for the treatment of primary biliary cirrhosis","volume":"91","author":"Bergasa","year":"1996","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2000.0109_RF39","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","article-title":"A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group","volume":"324","author":"Poupon","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0109_RF40","series-title":"Textbook of Medical Physiology","article-title":"Somatic sensations: II. Pain, headache, and thermal sensations","author":"Guyton","year":"1991"},{"key":"10.1053\/bega.2000.0109_RF41","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0140-6736(73)90797-6","article-title":"Scratching during sleep","volume":"ii","author":"Savin","year":"1973","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0109_RF42","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2133.1975.tb06496.x","article-title":"A new method for the measurement of itch and the response to treatment","volume":"93","author":"Felix","year":"1975","journal-title":"British Journal of Dermatology"},{"key":"10.1053\/bega.2000.0109_RF43","first-page":"400","article-title":"Application of piezo film technology for the quantitative assessment of pruritus","volume":"25","author":"Talbot","year":"1991","journal-title":"Biomedical Instrumentation and Technology"},{"key":"10.1053\/bega.2000.0109_RF44","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF02510746","article-title":"Improved device for measuring scratching activity in patients with pruritus","volume":"36","author":"Molenaar","year":"1998","journal-title":"Medical and Biological Engineering and Computing"},{"key":"10.1053\/bega.2000.0109_RF45","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/archderm.1979.04010110058029","article-title":"Relief of intractable pruritus with naloxone","volume":"115","author":"Bernstein","year":"1979","journal-title":"Archives of Dermatology"},{"key":"10.1053\/bega.2000.0109_RF46","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1136\/bmj.297.6662.1501","article-title":"Opioid peptides and primary biliary cirrhosis","volume":"297","author":"Thornton","year":"1988","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.2000.0109_RF47","series-title":"The Pharmacologic Basis of Therapeutics","first-page":"491","article-title":"Opioid analgesics and antagonists","author":"Jaffe","year":"1985"},{"key":"10.1053\/bega.2000.0109_RF48","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0304-3959(88)90085-1","article-title":"Itching after epidural and spinal opiates","volume":"33","author":"Ballantyne","year":"1988","journal-title":"Pain"},{"key":"10.1053\/bega.2000.0109_RF49","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1365-2044.1989.tb09116.x","article-title":"The incidence of pruritus after epidural morphine","volume":"44","author":"Ballantyne","year":"1989","journal-title":"Anaesthesia"},{"key":"10.1053\/bega.2000.0109_RF50","series-title":"Cecil Textbook of Medicine","first-page":"2300","article-title":"Skin diseases","author":"Parker","year":"1988"},{"key":"10.1053\/bega.2000.0109_RF51","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1001\/archderm.1948.01520180045006","article-title":"Experimental study of itch stimuli in animals","volume":"57","author":"Koenigstein","year":"1948","journal-title":"Archives of Dermatology and Syphilology"},{"key":"10.1053\/bega.2000.0109_RF52","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0006-8993(92)91227-6","article-title":"Effects of central administration of opioids on facial scratching in monkeys","volume":"585","author":"Thomas","year":"1992","journal-title":"Brain Research"},{"key":"10.1053\/bega.2000.0109_RF53","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0006-8993(95)00871-M","article-title":"Microinjection of morphine into the rat medullary dorsal horn produces a dose-dependent increase in facial scratching","volume":"695","author":"Thomas","year":"1995","journal-title":"Brain Research"},{"key":"10.1053\/bega.2000.0109_RF54","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.510270307","article-title":"Open label trial of oral nalmefene therapy for the pruritus of cholestasis","volume":"27","author":"Bergasa","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0109_RF55","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0190-9622(99)70117-9","article-title":"Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study","volume":"41","author":"Bergasa","year":"1999","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1053\/bega.2000.0109_RF56","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/hep.1840110526","article-title":"The pruritus of cholestasis: from bile acids to opiate agonists","volume":"11","author":"Jones","year":"1990","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0109_RF57","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0016-5085(92)90102-5","article-title":"A controlled trial of naloxone infusions for the pruritus of chronic cholestasis","volume":"102","author":"Bergasa","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0109_RF58","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-123-3-199508010-00001","article-title":"Naloxone ameliorates the pruritus of cholestasis: results of a double-blind randomized placebo-controlled trial","volume":"123","author":"Bergasa","year":"1995","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.2000.0109_RF59","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0168-8278(05)80471-4","article-title":"Cholestasis in the male rat is associated with naloxone-reversible antinociception","volume":"20","author":"Bergasa","year":"1994","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0109_RF60","first-page":"1022","article-title":"Pilot study of the use of naltrexone to treat the severe pruritus of cholestatic liver disease","volume":"91","author":"Carson","year":"1996","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2000.0109_RF61","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/gast.1997.v113.pm9322521","article-title":"Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study","volume":"113","author":"Wolfhagen","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0109_RF62","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0140-6736(86)91196-7","article-title":"Naltrexone and hepatotoxicity","volume":"i","author":"Mitchell","year":"1986","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0109_RF63","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0168-8278(97)80355-8","article-title":"Effect of liver cirrhosis on the systemic availability of naltrexone in humans","volume":"27","author":"Bertolotti","year":"1997","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0109_RF64","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0016-5085(00)70225-3","article-title":"Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis","volume":"118","author":"Jones","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0109_RF65","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0168-8278(92)90040-V","article-title":"Central mu-opioid receptors are down-regulated in a rat model of cholestasis","volume":"15","author":"Bergasa","year":"1992","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0109_RF66","first-page":"2018","article-title":"Methionine-enkephalin concentrations correlate with stage of disease but not pruritus in patients with primary biliary cirrhosis","volume":"89","author":"Spivey","year":"1994","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2000.0109_RF67","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0024-3205(87)90606-0","article-title":"Saturable transport of peptides across the blood\u2013brain barrier","volume":"41","author":"Banks","year":"1987","journal-title":"Life Sciences"},{"key":"10.1053\/bega.2000.0109_RF68","first-page":"346","article-title":"Cholestasis is associated with preproenkephalin mRNA expression in the adult rat liver","volume":"268","author":"Bergasa","year":"1995","journal-title":"American Journal of Physiology"},{"key":"10.1053\/bega.2000.0109_RF69","first-page":"295A","article-title":"Met-enkephalin immunoreactivity is present in the livers from patients with primary biliary cirrhosis (PBC)","volume":"26","author":"Bergasa","year":"1997","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0109_RF70","first-page":"1253","article-title":"Serum extracts from cholestatic patients induce naloxone-reversible centrally-mediated facial scratching in monkeys","volume":"53","author":"Bergasa","year":"1992","journal-title":"Life Sciences"},{"key":"10.1053\/bega.2000.0109_RF71","first-page":"1220","article-title":"Opioid peptides are substrates of the OATP gene family","volume":"30","author":"Gao","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0109_RF72","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1073\/pnas.91.1.133","article-title":"Expression cloning of a rat liver Na(+)-independent organic anion transporter","volume":"91","author":"Jacquemin","year":"1994","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/bega.2000.0109_RF73","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1177\/002215549904701005","article-title":"Localization of the organic anion transporting polypeptide 2 (Oatp2) in capillary endothelium and choroid plexus epithelium of rat brain","volume":"47","author":"Gao","year":"1999","journal-title":"Journal of Histochemistry and Cytochemistry"},{"key":"10.1053\/bega.2000.0109_RF74","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1749-6632.1990.tb16906.x","article-title":"Serotonin and nociception","volume":"600","author":"Richardson","year":"1990","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1053\/bega.2000.0109_RF75","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0006-8993(92)91490-6","article-title":"Serotonin receptor subtype antagonists in the medial ventral medulla inhibit mesencephalic opiate analgesia","volume":"597","author":"Kiefel","year":"1992","journal-title":"Brain Research"},{"key":"10.1053\/bega.2000.0109_RF76","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1749-6632.1990.tb16876.x","article-title":"Serotonin receptor \u2018families\u2019 in the central nervous system: an overview","volume":"600","author":"Peroutka","year":"1990","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1053\/bega.2000.0109_RF77","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0304-3959(94)00145-5","article-title":"Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron","volume":"61","author":"Schw\u00f6er","year":"1995","journal-title":"Pain"},{"key":"10.1053\/bega.2000.0109_RF78","first-page":"A1349","article-title":"Ondansetron in the treatment of the pruritus of cholestasis: a randomised controlled trial","volume":"112","author":"O'Donohue","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0109_RF79","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00042737-199810000-00010","article-title":"Treatment of pruritus of chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial","volume":"10","author":"Muller","year":"1998","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2000.0109_RF80","series-title":"Circadian Clocks and Their Adjustments","first-page":"88","article-title":"Organization of mammalian circadian system","author":"Moore","year":"1993"},{"key":"10.1053\/bega.2000.0109_RF81","first-page":"443(A)","article-title":"Effect of bright-light phototherapy (BLPT) directed towards the eyes for the pruritus of cholestasis: results of a pilot study","volume":"28","author":"Bergasa","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0109_RF82","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/0016-5085(90)91091-J","article-title":"Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study","volume":"98","author":"Balasubramaniam","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0109_RF83","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.1840120116","article-title":"The demography of primary biliary cirrhosis in Ontario, Canada","volume":"12","author":"Witt-Sullivan","year":"1990","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0109_RF84","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1572-0241.2000.01857.x","article-title":"Impact of fatigue on the quality of life of patients with primary biliary cirrhosis","volume":"95","author":"Huet","year":"2000","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2000.0109_RF85","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/gut.43.5.705","article-title":"Fatigue in primary biliary cirrhosis","volume":"43","author":"Cauch-Dudek","year":"1998","journal-title":"Gut"},{"key":"10.1053\/bega.2000.0109_RF86","first-page":"A162","article-title":"Patients with PBC have central but no peripheral fatigue","volume":"24","author":"Jalan","year":"1996","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0109_RF87","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep.510250239","article-title":"Is fatigue associated with cholestasis mediated by altered central neurotransmission?","volume":"25","author":"Jones","year":"1997","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0109_RF88","first-page":"1560","article-title":"Defective corticotropin-releasing hormone mediated neuroendocrine and behavioural responses in cholestatic rats: implications for cholestatic liver disease-related sickness behaviours","volume":"22","author":"Swain","year":"1995","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0109_RF89","first-page":"291","article-title":"Improvement in cholestasis-associated fatigue with a serotonin receptor agonist using a novel rat model of fatigue assessment","volume":"25","author":"Swain","year":"1997","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0109_RF90","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/hep.510280616","article-title":"Augmented interleukin-1beta-induced depression of locomotor activity in cholestatic rats","volume":"28","author":"Swain","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0109_RF91","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1113\/expphysiol.1992.sp003660","article-title":"Evidence for a possible role of 5-hydroxytryptamine in the genesis of fatigue in man: administration of paroxetine, a 5-HT re-uptake inhibitor, reduces the capacity to perform prolonged exercise","volume":"77","author":"Wilson","year":"1992","journal-title":"Experimental Physiology"},{"key":"10.1053\/bega.2000.0109_RF92","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(99)02936-0","article-title":"Relief from profound fatigue associated with chronic liver disease by long-term ondansetron therapy","volume":"354","author":"Jones","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0109_RF93","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/0016-5085(95)90709-2","article-title":"The pruritus of cholestasis: potential pathogenic and therapeutic implications of opioids","volume":"108","author":"Bergasa","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0109_RF94","first-page":"305","article-title":"Assessment of fatigue in cancer and non-cancer patients and in healthy individuals","volume":"1","author":"Glaus","year":"1993","journal-title":"Support Care Cancer"},{"key":"10.1053\/bega.2000.0109_RF95","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1547-5069.1999.tb00420.x","article-title":"Defining and measuring fatigue","volume":"31","author":"Aaronson","year":"1999","journal-title":"Image\u2013the Journal of Nursing Scholarship"},{"key":"10.1053\/bega.2000.0109_RF96","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/hep.510270204","article-title":"High prevalence of sleep disturbance in cirrhosis","volume":"27","author":"Cordoba","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0109_RF97","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0168-8278(00)80385-2","article-title":"Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use","volume":"32","author":"Prince","year":"2000","journal-title":"Journal of Hepatology"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691800901094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691800901094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:00:31Z","timestamp":1761498031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691800901094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":97,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["S1521691800901094"],"URL":"https:\/\/doi.org\/10.1053\/bega.2000.0109","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2000,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pruritus and fatigue in primary biliary cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/bega.2000.0109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Harcourt Publishers Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}